Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2018 · 10-Q
Revenue—
Net Income-$1.26M-$1.26MN/M vs Q2 2017 EPS Diluted-$0.16-$0.16N/M vs Q2 2017 Operating Income-$1,172,214N/M Operating Cash Flowderived-$703,590N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 13, 2018 · 44 d after period end